The PE Ratio as of December 2024 (TTM) for Abeona Therapeutics Inc. (ABEO) is -2.77

According to Abeona Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.77. This represents a change of 2.44% compared to the average of -0.11 of the last 4 quarters.

Abeona Therapeutics Inc. (ABEO) Historical PE Ratio (quarterly & annually)

How has ABEO PE Ratio performed in the past?

The mean historical PE Ratio of Abeona Therapeutics Inc. over the last ten years is -5.13. The current -2.77 PE Ratio has changed 5.30% with respect to the historical average. Over the past ten years (40 quarters), ABEO's PE Ratio was at its highest in in the June 2024 quarter at 5.67. The PE Ratio was at its lowest in in the September 2017 quarter at -32.21.

Abeona Therapeutics Inc. (ABEO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Abeona Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Abeona Therapeutics Inc. (ABEO) Average PE Ratio

How has ABEO PE Ratio performed in the past?

The current PE Ratio of Abeona Therapeutics Inc. (ABEO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Abeona Therapeutics Inc. (ABEO) PE Ratio vs. Peers

How is ABEO’s PE Ratio compared to its peers?

Abeona Therapeutics Inc.’s PE Ratio is less than Reviva Pharmaceuticals Holdings, Inc. (-1.80), less than Athira Pharma, Inc. (-0.19), less than Fortress Biotech, Inc. (-0.70), less than ACADIA Pharmaceuticals Inc. (22.05), less than Cabaletta Bio, Inc. (-1.10), less than Calithera Biosciences, Inc. (0), less than Affimed N.V. (-0.00), less than Checkpoint Therapeutics, Inc. (-0.26), greater than Adaptimmune Therapeutics plc (-3.38), greater than Mereo BioPharma Group plc (-3.29), greater than Pieris Pharmaceuticals, Inc. (-13.89), less than PDS Biotechnology Corporation (-1.13), less than Leap Therapeutics, Inc. (-1.49), less than X4 Pharmaceuticals, Inc. (-1.86), greater than Terns Pharmaceuticals, Inc. (-6.95), greater than Day One Biopharmaceuticals, Inc. (-5.12), greater than Inozyme Pharma, Inc. (-14.52), less than REGENXBIO Inc. (-1.92), less than Anebulo Pharmaceuticals, Inc. (-1.57), greater than Invivyd, Inc. (-5.30), less than Black Diamond Therapeutics, Inc. (-0.27), less than null (-1.69),

Build a custom stock screener for Abeona Therapeutics Inc. (ABEO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abeona Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abeona Therapeutics Inc. (ABEO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abeona Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.